While studying the effectiveness of the dietary treatment of patients with epilepsy, Dr. Pavel Klein observed that the diabetic patients in the study lost weight and showed signs of their diabetes entering remission. He learned that these observations were supported by a number of research studies showing the effectiveness of this dietary treatment in controlling and reversing type 2 diabetes. Building on this, from 2012 through 2015, Dr. Klein and his medical researchers conducted clinical studies on how his diet specifically affects patients with type 2 diabetes, and also worked to fine tune the nutrient balance and food recipes to create the most effective program at reversing diabetes available.
Dr. Pavel Klein is a neurologist with and clinical researcher with both a BA and MA from Oxford University and a MD from Cambridge University. Dr. Klein has taught at Harvard University and Georgetown University. He is now the founder and Director of the Mid-Atlantic Epilepsy and Sleep Center in Bethesda, MD.
Dr. Klein has published over 30 articles in peer-reviewed journals, has written numerous book chapters, presented scientific work at numerous national and international meetings, lectured nationally and internationally, and received grants from the NIH, from non-profit organizations and from the pharmaceutical industry for clinical scientific projects.
You can catch him at LowCarbUSA® – Winchester 2017 on October 21 where he will be speaking on the Keotgenic Diet and Type 2 Diabetes and again at LowCarbUSA® – San Diego 2018 in July where he will discuss the Ketogenic Diet and the treatment of Epilepsy.
Before founding Mid-Atlantic Epilepsy and Sleep Center, Dr. Klein was Instructor in Neurology at Harvard Medical School (1996-99), and Director of the Epilepsy Program, of the Clinical Neurophysiology Laboratory and of the Neuroendocrine Unit at the Georgetown University Hospital (1999-2003). Dr. Klein is currently Adjunct Associate Professor of Neurology at George Washington University. Dr. Klein’s clinical research includes novel treatments of epilepsy, dietary treatments of epilepsy in adults, prevention of epilepsy after traumatic brain injury, the effect of sex and stress hormones on epilepsy, and women with epilepsy. He has received grants from the National Institutes of Health and from the American Epilepsy Society. Dr. Klein has published more than 40 peer-reviewed articles and contributed chapters to several books on epilepsy. He acts as a reviewer for a number of neurological, epilepsy and endocrinological journals. He is a member of the American Epilepsy Society Scientific Program Committee, Treatment Committee, the Health Reform Task Force and the Co-Chair of the AES Private Practice Special Interest Group. His presentation on treatment of refractory epilepsy was ranked in the top 10% of all research presentations at the 2010 annual meeting of the American Epilepsy Society